After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Cassava Sciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Cassava Sciences Inc is $120.27M. A total of 1.09 million shares were traded on the day, compared to an average of 5.64M shares.
In the most recent transaction, Kupiec James William sold 4,000 shares of SAVA for 3.87 per share on Nov 29 ’24. After the transaction, the Chief Medical Officer now owns 0 company shares. In a previous transaction on Nov 29 ’24, Schoen Eric sold 59,800 shares at 3.86 per share. SAVA shares that Chief Financial Officer owns now total 11,500.
Among the insiders who sold shares, Schoen Eric disposed of 2,000 shares on Nov 29 ’24 at a per-share price of $3.82. This resulted in the Chief Financial Officer holding 0 shares of SAVA after the transaction. In another insider transaction, Schoen, Eric J. (SAVA) bought 2,000 shares at $3.82 per share on Nov 29 ’24.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SAVA has a high of $42.20 and a low of $2.23.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SAVA’s latest balance sheet shows that the firm has $233.44M in Cash & Short Term Investments as of fiscal 2021. There were $236.00k in debt and $12.53M in liabilities at the time. Its Book Value Per Share was $3.47, while its Total Shareholder’s Equity was $253.91M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SAVA is Buy with a score of 4.00.
